Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 343

1.

A Tablet App Supporting Self-Management for People With Dementia: Explorative Study of Adoption and Use Patterns.

Øksnebjerg L, Woods B, Ruth K, Lauridsen A, Kristiansen S, Holst HD, Waldemar G.

JMIR Mhealth Uhealth. 2020 Jan 17;8(1):e14694. doi: 10.2196/14694.

2.

Microstate Changes Associated With Alzheimer's Disease in Persons With Down Syndrome.

Musaeus CS, Salem LC, Kjaer TW, Waldemar G.

Front Neurosci. 2019 Nov 28;13:1251. doi: 10.3389/fnins.2019.01251. eCollection 2019.

3.

The Use of Opioids and Antipsychotics in Elderly with Dementia - Have Opioids Replaced Antipsychotics in Treating Behavioral Symptoms in Dementia?

Jensen-Dahm C, Christensen AN, Gasse C, Waldemar G.

J Alzheimers Dis. 2020;73(1):259-267. doi: 10.3233/JAD-190787.

PMID:
31771062
4.

Assistive technology designed to support self-management of people with dementia: user involvement, dissemination, and adoption. A scoping review.

Øksnebjerg L, Janbek J, Woods B, Waldemar G.

Int Psychogeriatr. 2019 Nov 25:1-17. doi: 10.1017/S1041610219001704. [Epub ahead of print]

PMID:
31762431
5.

Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline.

Jokinen H, Koikkalainen J, Laakso HM, Melkas S, Nieminen T, Brander A, Korvenoja A, Rueckert D, Barkhof F, Scheltens P, Schmidt R, Fazekas F, Madureira S, Verdelho A, Wallin A, Wahlund LO, Waldemar G, Chabriat H, Hennerici M, O'Brien J, Inzitari D, Lötjönen J, Pantoni L, Erkinjuntti T.

Stroke. 2020 Jan;51(1):170-178. doi: 10.1161/STROKEAHA.119.026170. Epub 2019 Nov 8.

6.

Broad consent for biobanks is best - provided it is also deep.

Mikkelsen RB, Gjerris M, Waldemar G, Sandøe P.

BMC Med Ethics. 2019 Oct 15;20(1):71. doi: 10.1186/s12910-019-0414-6.

7.

Declining incidence of dementia: A national registry-based study over 20 years.

Taudorf L, Nørgaard A, Islamoska S, Jørgensen K, Laursen TM, Waldemar G.

Alzheimers Dement. 2019 Nov;15(11):1383-1391. doi: 10.1016/j.jalz.2019.07.006. Epub 2019 Oct 3.

8.

Determining Filipino Normative Data for a Battery of Neuropsychological Tests: The Filipino Norming Project (FNP).

Dominguez JC, Phung TKT, de Guzman MFP, Fowler KC, Reandelar M Jr, Natividad B, Waldemar G, Nielsen TR, Pamintuan Aquial MR, Holandez RL, Ligsay AD.

Dement Geriatr Cogn Dis Extra. 2019 Aug 13;9(2):260-270. doi: 10.1159/000500519. eCollection 2019 May-Aug.

9.

Trend in the Incidence and Prevalence of Dementia in the Faroe Islands.

Petersen MS, Restorff M, Stórá T, Waldemar G, Joensen S.

J Alzheimers Dis. 2019;71(3):969-978. doi: 10.3233/JAD-190341.

10.

Self-management and cognitive rehabilitation in early stage dementia - merging methods to promote coping and adoption of assistive technology. A pilot study.

Øksnebjerg L, Woods B, Vilsen CR, Ruth K, Gustafsson M, Ringkøbing SP, Waldemar G.

Aging Ment Health. 2019 Aug 20:1-10. doi: 10.1080/13607863.2019.1625302. [Epub ahead of print]

PMID:
31429315
11.

Oscillatory connectivity as a diagnostic marker of dementia due to Alzheimer's disease.

Musaeus CS, Engedal K, Høgh P, Jelic V, Mørup M, Naik M, Oeksengaard AR, Snaedal J, Wahlund LO, Waldemar G, Andersen BB.

Clin Neurophysiol. 2019 Oct;130(10):1889-1899. doi: 10.1016/j.clinph.2019.07.016. Epub 2019 Jul 29.

PMID:
31408790
12.

Brief Assessment of Impaired Cognition (BASIC)-Validation of a new dementia case-finding instrument integrating cognitive assessment with patient and informant report.

Jørgensen K, Nielsen TR, Nielsen A, Waldorff FB, Høgh P, Jakobsen S, Gottrup H, Vestergaard K, Waldemar G.

Int J Geriatr Psychiatry. 2019 Nov;34(11):1724-1733. doi: 10.1002/gps.5188. Epub 2019 Aug 19.

13.

Geographical Variation in Opioid Use in Elderly Patients with Dementia: A Nationwide Study.

Jensen-Dahm C, Zakarias JK, Gasse C, Waldemar G.

J Alzheimers Dis. 2019;70(4):1209-1216. doi: 10.3233/JAD-190413.

14.

Midlife Forgetfulness and Risk of Dementia in Old Age: Results from the Danish Working Environment Cohort Study.

Ishtiak-Ahmed K, Hansen ÅM, Mortensen EL, Garde AH, Brødsgaard Grynderup M, Gyntelberg F, Islamoska S, Lund R, Phung TKT, Prescott E, Waldemar G, Nabe-Nielsen K.

Dement Geriatr Cogn Disord. 2019;47(4-6):264-273. doi: 10.1159/000500184. Epub 2019 Jul 18.

PMID:
31319407
15.

Designing the ReACT App to Support Self-Management of People with Dementia: An Iterative User-Involving Process.

Øksnebjerg L, Woods B, Waldemar G.

Gerontology. 2019;65(6):673-685. doi: 10.1159/000500445. Epub 2019 Jul 2.

16.

Moderate- to high-intensity exercise does not modify cortical β-amyloid in Alzheimer's disease.

Frederiksen KS, Madsen K, Andersen BB, Beyer N, Garde E, Høgh P, Waldemar G, Hasselbalch SG, Law I.

Alzheimers Dement (N Y). 2019 Jun 7;5:208-215. doi: 10.1016/j.trci.2019.04.006. eCollection 2019.

17.

Perceived stress and dementia: Results from the Copenhagen city heart study.

Nabe-Nielsen K, Rod NH, Hansen ÅM, Prescott E, Grynderup MB, Islamoska S, Ishtiak-Ahmed K, Garde AH, Gyntelberg F, Mortensen EL, Phung TKT, Waldemar G, Westendorp RGJ.

Aging Ment Health. 2019 Jun 11:1-9. doi: 10.1080/13607863.2019.1625304. [Epub ahead of print]

PMID:
31184203
18.

Barriers to post-diagnostic care and support in minority ethnic communities: A survey of Danish primary care dementia coordinators.

Nielsen TR, Nielsen DS, Waldemar G.

Dementia (London). 2019 Jun 5:1471301219853945. doi: 10.1177/1471301219853945. [Epub ahead of print]

PMID:
31167555
19.

Night shift work, long working hours and dementia: a longitudinal study of the Danish Work Environment Cohort Study.

Nabe-Nielsen K, Hansen ÅM, Ishtiak-Ahmed K, Grynderup MB, Gyntelberg F, Islamoska S, Mortensen EL, Phung TKT, Rod NH, Waldemar G, Westendorp RGJ, Garde AH.

BMJ Open. 2019 May 24;9(5):e027027. doi: 10.1136/bmjopen-2018-027027.

20.

Cognitive Advantages in Adult Turkish Bilingual Immigrants - a Question of the Chicken or the Egg.

Nielsen TR, Antelius E, Waldemar G.

J Cross Cult Gerontol. 2019 Jun;34(2):115-129. doi: 10.1007/s10823-019-09375-7.

PMID:
31119462
21.

Associations between electroencephalography power and Alzheimer's disease in persons with Down syndrome.

Musaeus CS, Salem LC, Sabers A, Kjaer TW, Waldemar G.

J Intellect Disabil Res. 2019 Sep;63(9):1151-1157. doi: 10.1111/jir.12627. Epub 2019 Apr 25.

PMID:
31025465
22.

Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise.

Jensen CS, Simonsen AH, Siersma V, Beyer N, Frederiksen KS, Gottrup H, Hoffman K, Høgh P, Frikke-Schmidt R, Sobol NA, Waldemar G, Wermuth L, Hasselbalch SG.

Alzheimers Dement (N Y). 2019 Apr 8;5:99-106. doi: 10.1016/j.trci.2019.02.007. eCollection 2019.

23.

Geographical Variation in the Diagnostic Rate and Quality of Dementia Diagnoses.

Zakarias JK, Jensen-Dahm C, Nørgaard A, Roos P, Gasse C, Phung TKT, Waldemar G.

J Alzheimers Dis. 2019;69(2):513-520. doi: 10.3233/JAD-190030.

PMID:
30958374
24.

Validation of a brief Multicultural Cognitive Examination (MCE) for evaluation of dementia.

Nielsen TR, Segers K, Vanderaspoilden V, Beinhoff U, Minthon L, Pissiota A, Bekkhus-Wetterberg P, Bjørkløf GH, Tsolaki M, Gkioka M, Waldemar G.

Int J Geriatr Psychiatry. 2019 Jul;34(7):982-989. doi: 10.1002/gps.5099. Epub 2019 Apr 23.

PMID:
30901493
25.

Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study.

Bruun M, Frederiksen KS, Rhodius-Meester HFM, Baroni M, Gjerum L, Koikkalainen J, Urhemaa T, Tolonen A, van Gils M, Rueckert D, Dyremose N, Andersen BB, Lemstra AW, Hallikainen M, Kurl S, Herukka SK, Remes AM, Waldemar G, Soininen H, Mecocci P, van der Flier WM, Lötjönen J, Hasselbalch SG.

Alzheimers Res Ther. 2019 Mar 20;11(1):25. doi: 10.1186/s13195-019-0482-3.

26.

Physical Activity as a Moderator of Alzheimer Pathology: A Systematic Review of Observational Studies.

Frederiksen KS, Gjerum L, Waldemar G, Hasselbalch SG.

Curr Alzheimer Res. 2019;16(4):362-378. doi: 10.2174/1567205016666190315095151.

PMID:
30873924
27.

Detecting frontotemporal dementia syndromes using MRI biomarkers.

Bruun M, Koikkalainen J, Rhodius-Meester HFM, Baroni M, Gjerum L, van Gils M, Soininen H, Remes AM, Hartikainen P, Waldemar G, Mecocci P, Barkhof F, Pijnenburg Y, van der Flier WM, Hasselbalch SG, Lötjönen J, Frederiksen KS.

Neuroimage Clin. 2019;22:101711. doi: 10.1016/j.nicl.2019.101711. Epub 2019 Feb 4.

28.

Changes in the Prevalence of Polypharmacy in People with and without Dementia from 2000 to 2014: A Nationwide Study.

Kristensen RU, Nørgaard A, Jensen-Dahm C, Gasse C, Wimberley T, Waldemar G.

J Alzheimers Dis. 2019;67(3):949-960. doi: 10.3233/JAD-180427.

PMID:
30689562
29.

Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study.

Bruun M, Frederiksen KS, Rhodius-Meester HFM, Baroni M, Gjerum L, Koikkalainen J, Urhemaa T, Tolonen A, van Gils M, Tong T, Guerrero R, Rueckert D, Dyremose N, Andersen BB, Simonsen AH, Lemstra A, Hallikainen M, Kurl S, Herukka SK, Remes AM, Waldemar G, Soininen H, Mecocci P, van der Flier WM, Lötjönen J, Hasselbalch SG.

Curr Alzheimer Res. 2019;16(2):91-101. doi: 10.2174/1567205016666190103152425.

PMID:
30605060
30.

Vital Exhaustion and Incidence of Dementia: Results from the Copenhagen City Heart Study.

Islamoska S, Ishtiak-Ahmed K, Hansen ÅM, Grynderup MB, Mortensen EL, Garde AH, Gyntelberg F, Prescott EIB, Török E, Waldemar G, Nabe-Nielsen K.

J Alzheimers Dis. 2019;67(1):369-379. doi: 10.3233/JAD-180478.

31.

Prolonged or serious conflicts at work and incident dementia: a 23-year follow-up of the Copenhagen City Heart Study.

Ishtiak-Ahmed K, Hansen ÅM, Mortensen EL, Garde AH, Nørgaard A, Gyntelberg F, Rod NH, Islamoska S, Lund R, Phung TKT, Prescott E, Waldemar G, Nabe-Nielsen K.

Int Arch Occup Environ Health. 2019 Feb;92(2):165-173. doi: 10.1007/s00420-018-1365-9. Epub 2018 Oct 28.

32.

Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.

Ramos de Matos M, Ferreira C, Herukka SK, Soininen H, Janeiro A, Santana I, Baldeiras I, Almeida MR, Lleó A, Dols-Icardo O, Alcolea D, Benussi L, Binetti G, Paterlini A, Ghidoni R, Nacmias B, Meulenbroek O, van Waalwijk van Doorn LJC, Kuiperi HBJ, Hausner L, Waldemar G, Simonsen AH, Tsolaki M, Gkatzima O, Resende de Oliveira C, Verbeek MM, Clarimon J, Hiltunen M, de Mendonça A, Martins M.

J Alzheimers Dis. 2018;66(2):639-652. doi: 10.3233/JAD-180512.

PMID:
30320580
33.

Evaluating combinations of diagnostic tests to discriminate different dementia types.

Bruun M, Rhodius-Meester HFM, Koikkalainen J, Baroni M, Gjerum L, Lemstra AW, Barkhof F, Remes AM, Urhemaa T, Tolonen A, Rueckert D, van Gils M, Frederiksen KS, Waldemar G, Scheltens P, Mecocci P, Soininen H, Lötjönen J, Hasselbalch SG, van der Flier WM.

Alzheimers Dement (Amst). 2018 Aug 17;10:509-518. doi: 10.1016/j.dadm.2018.07.003. eCollection 2018.

34.

Validation of a European Cross-Cultural Neuropsychological Test Battery (CNTB) for evaluation of dementia.

Nielsen TR, Segers K, Vanderaspoilden V, Beinhoff U, Minthon L, Pissiota A, Bekkhus-Wetterberg P, Bjørkløf GH, Tsolaki M, Gkioka M, Waldemar G.

Int J Geriatr Psychiatry. 2019 Jan;34(1):144-152. doi: 10.1002/gps.5002. Epub 2018 Oct 17.

PMID:
30246268
35.

Inflammatory markers of CHMP2B-mediated frontotemporal dementia.

Roos P, von Essen MR, Nielsen TT, Johannsen P, Stokholm J, Bie AS, Waldemar G, Simonsen AH, Heslegrave A, Zetterberg H; FReJA consortium, Sellebjerg F, Nielsen JE.

J Neuroimmunol. 2018 Nov 15;324:136-142. doi: 10.1016/j.jneuroim.2018.08.009. Epub 2018 Aug 17.

PMID:
30193769
36.

Subjective memory complaints and future depression in primary care patients: A four-year follow-up study.

Quaade AS, Davidsen AS, Siersma V, Waldemar G, Waldorff FB.

Gen Hosp Psychiatry. 2018 Nov - Dec;55:4-9. doi: 10.1016/j.genhosppsych.2018.08.008. Epub 2018 Aug 22.

PMID:
30176576
37.

Long-term medical costs of Alzheimer's disease: matched cohort analysis.

Sopina E, Spackman E, Martikainen J, Waldemar G, Sørensen J.

Eur J Health Econ. 2019 Apr;20(3):333-342. doi: 10.1007/s10198-018-1004-0. Epub 2018 Aug 31.

PMID:
30171490
38.

Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.

Sobol NA, Dall CH, Høgh P, Hoffmann K, Frederiksen KS, Vogel A, Siersma V, Waldemar G, Hasselbalch SG, Beyer N.

J Alzheimers Dis. 2018;65(1):137-145. doi: 10.3233/JAD-180253.

39.

Validation of the Rowland Universal Dementia Assessment Scale (RUDAS) in a multicultural sample across five Western European countries: diagnostic accuracy and normative data.

Nielsen TR, Segers K, Vanderaspoilden V, Bekkhus-Wetterberg P, Bjørkløf GH, Beinhoff U, Minthon L, Pissiota A, Tsolaki M, Gkioka M, Waldemar G.

Int Psychogeriatr. 2019 Feb;31(2):287-296. doi: 10.1017/S1041610218000832. Epub 2018 Jul 18.

PMID:
30017010
40.

EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer's Disease.

Musaeus CS, Engedal K, Høgh P, Jelic V, Mørup M, Naik M, Oeksengaard AR, Snaedal J, Wahlund LO, Waldemar G, Andersen BB.

J Alzheimers Dis. 2018;64(4):1359-1371. doi: 10.3233/JAD-180300.

PMID:
29991135
41.

Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier.

Tolonen A, Rhodius-Meester HFM, Bruun M, Koikkalainen J, Barkhof F, Lemstra AW, Koene T, Scheltens P, Teunissen CE, Tong T, Guerrero R, Schuh A, Ledig C, Baroni M, Rueckert D, Soininen H, Remes AM, Waldemar G, Hasselbalch SG, Mecocci P, van der Flier WM, Lötjönen J.

Front Aging Neurosci. 2018 Apr 25;10:111. doi: 10.3389/fnagi.2018.00111. eCollection 2018.

42.

The process of disclosing a diagnosis of dementia and mild cognitive impairment: A national survey of specialist physicians in Denmark.

Nielsen TR, Svensson BH, Rohr G, Gottrup H, Vestergaard K, Høgh P, Waldemar G.

Dementia (London). 2018 Jan 1:1471301218777443. doi: 10.1177/1471301218777443. [Epub ahead of print]

PMID:
29806491
43.

Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis.

Cajanus A, Hall A, Koikkalainen J, Solje E, Tolonen A, Urhemaa T, Liu Y, Haanpää RM, Hartikainen P, Helisalmi S, Korhonen V, Rueckert D, Hasselbalch S, Waldemar G, Mecocci P, Vanninen R, van Gils M, Soininen H, Lötjönen J, Remes AM.

Dement Geriatr Cogn Dis Extra. 2018 Feb 23;8(1):51-59. doi: 10.1159/000486849. eCollection 2018 Jan-Apr.

44.

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleo A, Molinuevo JL, Jagust WJ, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimalla R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka SK, Johannsen P, van Laere K, de Leon MJ, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R.

Alzheimers Dement. 2018 Jul;14(7):913-924. doi: 10.1016/j.jalz.2018.02.009. Epub 2018 Mar 28.

PMID:
29601787
45.

Polypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study.

Kristensen RU, Nørgaard A, Jensen-Dahm C, Gasse C, Wimberley T, Waldemar G.

J Alzheimers Dis. 2018;63(1):383-394. doi: 10.3233/JAD-170905.

PMID:
29578483
46.

Performance of middle-aged and elderly European minority and majority populations on a Cross-Cultural Neuropsychological Test Battery (CNTB).

Nielsen TR, Segers K, Vanderaspoilden V, Bekkhus-Wetterberg P, Minthon L, Pissiota A, Bjørkløf GH, Beinhoff U, Tsolaki M, Gkioka M, Waldemar G.

Clin Neuropsychol. 2018 Nov;32(8):1411-1430. doi: 10.1080/13854046.2018.1430256. Epub 2018 Jan 24.

PMID:
29364089
47.

Socio-demographic and cardiovascular disease risk factors associated with dementia: Results of a cross-sectional study from Lebanon.

Chaaya M, Phung K, Atweh S, El Asmar K, Karam G, Khoury RM, Ghandour L, Ghusn H, Assaad S, Prince M, Waldemar G.

Prev Med Rep. 2017 Nov 24;9:1-5. doi: 10.1016/j.pmedr.2017.11.006. eCollection 2018 Mar.

48.

Communicating Identifiability Risks to Biobank Donors.

Kasperbauer TJ, Gjerris M, Waldemar G, Sandøe P.

Camb Q Healthc Ethics. 2018 Jan;27(1):123-136. doi: 10.1017/S0963180117000457.

PMID:
29214966
49.

Social Relations at Work and Incident Dementia: 29-Years' Follow-Up of the Copenhagen Male Study.

Ishtiak-Ahmed K, Hansen ÅM, Garde AH, Mortensen EL, Gyntelberg F, Phung TKT, Lund R, Rod NH, Prescott E, Waldemar G, Westendorp R, Nabe-Nielsen K.

J Occup Environ Med. 2018 Jan;60(1):12-18. doi: 10.1097/JOM.0000000000001158.

50.

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.

Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Köhler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodríguez-Rodríguez E, Roe CM, Rot U, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Zetterberg H.

JAMA Psychiatry. 2018 Jan 1;75(1):84-95. doi: 10.1001/jamapsychiatry.2017.3391. Erratum in: JAMA Psychiatry. 2018 Mar 1;75(3):303.

Supplemental Content

Loading ...
Support Center